Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm
Background and aims. The Barcelona Clinic Liver Cancer (BCLC) staging system is the algorithm most widely used to manage patients with hepatocellular carcinoma (HCC). We aimed to investigate the extent to which the BCLC recommendations effectively guide clinical practice and assess the reasons for a...
Main Authors: | Mandy Richani, Philippe Kolly, Marina Knoepfli, Evelyn Herrmann, Martin Zweifel, Hendrik von Tengg-Kobligk, Daniel Candinas, Jean-François Dufour |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119307446 |
Similar Items
-
Comparison of Survival Rates Based on Recommended Treatment Algorithms of BCLC or HKLC Staging Systems for Hepatocellar Carcinoma Patients
by: DENG Guoyu, et al.
Published: (2019-04-01) -
Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C
by: Qin Wei, et al.
Published: (2017-11-01) -
Clinical Profile and Treatment of Hepatocellular Carcinoma: A Single-Center Experience
by: Abu B. H. Bhatti, et al.
Published: (2021-04-01) -
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)
by: Masatoshi Kudo, et al.
Published: (2021-07-01) -
Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region
by: Ana Matilla Peña, et al.
Published: (2015-03-01)